This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignee: Future Medicine Co., Ltd.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Innovations by Sang Koo Lee in Pharmaceutical Composition
Introduction
Sang Koo Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of eye diseases and liver conditions. With a total of 3 patents, his work has the potential to impact many lives.
Latest Patents
Sang Koo Lee's latest patents include a pharmaceutical composition for preventing and treating glaucoma, which contains an adenosine derivative. This composition aims to provide effective treatment for eye diseases by utilizing a specific compound as an active ingredient. Another important patent focuses on a pharmaceutical composition for preventing and treating nonalcoholic steatohepatitis, hepatic fibrosis, and liver cirrhosis, also comprising adenosine derivatives. This innovative approach highlights the versatility of adenosine compounds in addressing various health issues.
Career Highlights
Throughout his career, Sang Koo Lee has demonstrated a commitment to advancing medical science through his inventions. His work at Future Medicine Co., Ltd. has positioned him as a key player in the pharmaceutical industry. His research and development efforts have led to groundbreaking solutions for complex health problems.
Collaborations
Sang Koo Lee has collaborated with esteemed colleagues such as Chong Woo Park and Hea Ok Kim. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Sang Koo Lee's contributions to pharmaceutical compositions reflect his dedication to improving health outcomes. His innovative patents in treating eye and liver diseases showcase the importance of research and development in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile